TerminatedNCT00464191
Escitalopram in Depression in bipolarity: a Placebo-controlled Study of Acute and Maintenance Treatment
Medication studyAges 18–70Norway
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
- Listed locations
- NordfjordeidSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateApril 2006
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 150
- Sponsor
- Nordfjord Psychiatric Centre
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Norway
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT00464191
- Official title
Show the full official title
Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Nordfjordeid
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Nordfjord Psychiatric Centre.
Does this study involve medication?
Yes. The study involves medication, including escitalopram.
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
